Form 4 Tracker
Nello Mainolfi

Director, Chief Executive Officer · 4 filings · Latest: Apr 29, 2026

Kymera Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KYMR
Nello MainolfiDirector, Chief Executive OfficerApr 29, 2026
Sale
$81.1830,000$2.4M666,195
KYMR
Nello MainolfiDirector, Chief Executive OfficerApr 29, 2026
Option Exercise
$2.0830,000$62.4K696,195
KYMR
Mainolfi NelloApr 29, 2026
Proposed Sale
$82.4730,000$2.5M
KYMR
Nello MainolfiDirector, Chief Executive OfficerFeb 25, 2026
Sale
$90.2630,000$2.7M666,195
KYMR
Nello MainolfiDirector, Chief Executive OfficerFeb 25, 2026
Option Exercise
$2.0830,000$62.4K696,195
KYMR
Mainolfi NelloFeb 25, 2026
Proposed Sale
$91.4030,000$2.7M
KYMR
Nello MainolfiDirector, Chief Executive OfficerDec 31, 2025
Sale
$78.0630,000$2.3M663,077
KYMR
Nello MainolfiDirector, Chief Executive OfficerDec 31, 2025
Option Exercise
$2.0830,000$62.4K693,077
KYMR
Mainolfi NelloDec 31, 2025
Proposed Sale
$77.6930,000$2.3M
KYMR
Mainolfi NelloDec 8, 2025
Proposed Sale
$89.17100,000$8.9M
KYMR
Mainolfi NelloOct 29, 2025
Proposed Sale
$61.6830,000$1.9M
KYMR
Mainolfi NelloSep 16, 2025
Proposed Sale
$49.0030,000$1.5M
KYMR
Mainolfi NelloJun 3, 2025
Proposed Sale
$49.0030,000$1.5M